Dr. Charles A. Leath
Claim this profileUniversity of Alabama at Birmingham Cancer Center
Studies Endometrioid Adenocarcinoma
Studies Endometrial Cancer
12 reported clinical trials
30 drugs studied
Area of expertise
1Endometrioid Adenocarcinoma
Stage III
Stage IV
MMR negative
2Endometrial Cancer
Stage III
Stage IV
MMR negative
Affiliated Hospitals
Clinical Trials Charles A. Leath is currently running
Dostarlimab
for Advanced Cancer
This trial is testing dostarlimab, a medicine that helps the immune system fight cancer, in patients with advanced solid tumors who have limited treatment options. It works by blocking a protein that allows cancer cells to hide from the immune system. Dostarlimab has garnered extensive interest for its ability to activate the immune system to respond to cancer cells.
Recruiting1 award Phase 110 criteria
Surgical Procedures
for Reducing Ovarian Cancer Risk
This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk reduction for women with BRCA1 mutations.
Recruiting1 award N/A
More about Charles A. Leath
Clinical Trial Related5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Charles A. Leath has experience with
- External Beam Radiation Therapy
- Brachytherapy
- Pembrolizumab
- Paclitaxel
- Topotecan
- Mirvetuximab Soravtansine
Breakdown of trials Charles A. Leath has run
Endometrioid Adenocarcinoma
Endometrial Cancer
Endometrial Adenocarcinoma
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles A. Leath specialize in?
Charles A. Leath focuses on Endometrioid Adenocarcinoma and Endometrial Cancer. In particular, much of their work with Endometrioid Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Charles A. Leath currently recruiting for clinical trials?
Yes, Charles A. Leath is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Charles A. Leath has studied deeply?
Yes, Charles A. Leath has studied treatments such as External Beam Radiation Therapy, Brachytherapy, Pembrolizumab.
What is the best way to schedule an appointment with Charles A. Leath?
Apply for one of the trials that Charles A. Leath is conducting.
What is the office address of Charles A. Leath?
The office of Charles A. Leath is located at: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama 35233 United States. This is the address for their practice at the University of Alabama at Birmingham Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.